ClinicalTrials.Veeva

Menu

Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy

S

Shanghai University of Traditional Chinese Medicine

Status

Unknown

Conditions

Idiopathic Membranous Nephropathy

Treatments

Drug: The Comprehensive Treatment Regimen of Traditional Chinese Medicine
Drug: The immunosuppressive agents

Study type

Observational

Funder types

Other

Identifiers

NCT01799460
11YZ65 (Other Grant/Funding Number)
ShanghaiMEC-2011

Details and patient eligibility

About

The purpose of this study is to analysis the different genotype in the idiopathic membranous nephropathy patients which with different therapeutic outcomes after treated by the Comprehensive Treatment Regimen or immunosuppressive agents, and so as to looking for ideal markers to assess appropriate treatment approach and the long-term efficacy.

Full description

The primary objective of this study is to looking for the gene level predictors in the patients who suffered from idiopathic membranous nephropathy. And according to the predictors, the clinicians could make a decision which method should be taken on IMN patients, Traditional Chinese Medicine or western medicine, and could get better results.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of idiopathic membranous nephropathy
  • Chronic Kidney Disease (CKD)≤3 stage(Glomerular Filtration Rate (GFR)≥30ml/min)and 24 hour urinary protein≥3g
  • Voluntarily participated in the study and signed an informed consent

Exclusion criteria

  • Combined life-threatening complications such as serious infection
  • Abnormal glucose metabolism
  • Patients with malignant tumors or malignancy , HIV infection and a history of mental illness , acute central nervous system disease , serious gastrointestinal diseases,etc
  • Pregnancy or breast-feeding women
  • Undergoing other clinical trials

Trial design

80 participants in 4 patient groups

CR/CTR group
Description:
The complete remission group treated by the Comprehensive Treatment Regimen
Treatment:
Drug: The Comprehensive Treatment Regimen of Traditional Chinese Medicine
NR/CTR group
Description:
The non-remission group treated by the Comprehensive Treatment Regimen
Treatment:
Drug: The Comprehensive Treatment Regimen of Traditional Chinese Medicine
CR/IA group
Description:
The complete remission group treated by Immunosuppressive Agents
Treatment:
Drug: The immunosuppressive agents
NR/IA group
Description:
The non-remission group treated by Immunosuppressive Agents.
Treatment:
Drug: The immunosuppressive agents

Trial contacts and locations

1

Loading...

Central trial contact

Wang Lin, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems